Actinium Pharmaceuticals, Inc. (ATNM)
1.56
+0.18
(+13.04%)
USD |
NYAM |
Oct 22, 15:52
Actinium Pharmaceuticals Price to Book Value : 1.619 for Oct. 22, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 21, 2026 | 1.432 |
| October 20, 2026 | 1.453 |
| October 19, 2026 | 1.370 |
| October 16, 2026 | 1.172 |
| October 15, 2026 | 1.100 |
| October 14, 2026 | 1.011 |
| October 13, 2026 | 1.037 |
| October 12, 2026 | 1.100 |
| October 09, 2026 | 1.141 |
| October 08, 2026 | 1.121 |
| October 07, 2026 | 1.110 |
| October 06, 2026 | 1.152 |
| October 05, 2026 | 1.245 |
| October 02, 2026 | 1.214 |
| October 01, 2026 | 1.193 |
| September 30, 2026 | 1.162 |
| September 29, 2026 | 1.183 |
| September 28, 2026 | 1.224 |
| September 25, 2026 | 1.245 |
| September 24, 2026 | 1.235 |
| September 23, 2026 | 1.224 |
| September 22, 2026 | 1.214 |
| September 21, 2026 | 1.245 |
| September 18, 2026 | 1.266 |
| September 17, 2026 | 1.235 |
| Date | Value |
|---|---|
| September 16, 2026 | 1.287 |
| September 15, 2026 | 1.297 |
| September 14, 2026 | 1.328 |
| September 11, 2026 | 1.453 |
| September 10, 2026 | 1.359 |
| September 09, 2026 | 1.276 |
| September 08, 2026 | 1.276 |
| September 04, 2026 | 1.069 |
| September 03, 2026 | 1.090 |
| September 02, 2026 | 1.038 |
| September 01, 2026 | 1.033 |
| August 31, 2026 | 1.058 |
| August 28, 2026 | 1.048 |
| August 27, 2026 | 1.038 |
| August 26, 2026 | 1.048 |
| August 25, 2026 | 1.121 |
| August 24, 2026 | 1.090 |
| August 21, 2026 | 1.141 |
| August 20, 2026 | 1.162 |
| August 19, 2026 | 1.172 |
| August 18, 2026 | 1.121 |
| August 17, 2026 | 1.090 |
| August 14, 2026 | 1.079 |
| August 13, 2026 | 1.000 |
| August 12, 2026 | 0.852 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.672 |
| Alnylam Pharmaceuticals, Inc. | 22.36 |
| Anika Therapeutics, Inc. | 2.040 |
| Savara, Inc. | 6.448 |
| Vericel Corp. | 5.921 |
Price to Book Value Related Metrics
| PE Ratio | 4.373 |
| PS Ratio | 1.390 |
| Price | 1.56 |
| Earnings Yield | 22.87% |
| Market Cap | 49.05M |
| Operating PE Ratio | 5.103 |
| Normalized PE Ratio | 4.373 |